Anixa Biosciences Inc. (NASDAQ: ANIX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ANIXA BIOSCIENCES INC.

Anixa Biosciences Inc. (NASDAQ: ANIX)
Listen to this Section


$2.52
-0.1000 ( -3.82% ) 56.2K

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Market Data


Open $2.52
Previous Close $2.62
Volume 56.2K
Market Cap $84.49M
Day Range $2.50 - $2.70
52 Week Range $2.44 - $5.46
Shares Outstanding 33.53M
Change % -3.82%
Net Change ▼ -0.1000
Insider Ownership -0.11%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year1983
CountryUnited States

SEC Filings


Form Type Description Pages Date
8-k 8K-related 34 Mar 11, 2026
10-q Quarterly Reports 60 Mar 09, 2026
8-k 8K-related 14 Feb 09, 2026
4 Insider transactions 1 Jan 29, 2026
def Proxies and info statements 19 Jan 28, 2026
10-k Annual reports 65 Jan 12, 2026
s-8 Registration statements 14 Jan 12, 2026
4 Insider transactions 1 Jan 06, 2026
4 Insider transactions 1 Jan 06, 2026
schedule Other 1 Jan 06, 2026

Latest News


× Before browsing our site, please accept our cookies policy